Genomic responses in mouse models poorly mimic human inflammatory diseasesJunhee Seok, David Schoenfeld, Henry V. Baker et al.|Proceedings of the National Academy of Sciences|2013Cited by 3k
Lisaftoclax (APG-2575) Safety and Activity As Monotherapy or Combined with Acalabrutinib or Rituximab in Patients (pts) with Treatment-Naïve, Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (R/R CLL/SLL): Initial Data from a Phase 2 Global StudyMatthew S. Davids, Yifan Zhai, Asher Chanan‐Khan et al.|Blood|2022Cited by 16